BR112016028285A2 - métodos para colheita de culturas de células de mamíferos - Google Patents

métodos para colheita de culturas de células de mamíferos

Info

Publication number
BR112016028285A2
BR112016028285A2 BR112016028285A BR112016028285A BR112016028285A2 BR 112016028285 A2 BR112016028285 A2 BR 112016028285A2 BR 112016028285 A BR112016028285 A BR 112016028285A BR 112016028285 A BR112016028285 A BR 112016028285A BR 112016028285 A2 BR112016028285 A2 BR 112016028285A2
Authority
BR
Brazil
Prior art keywords
methods
mammalian cell
cell cultures
harvesting mammalian
harvesting
Prior art date
Application number
BR112016028285A
Other languages
English (en)
Other versions
BR112016028285B1 (pt
Inventor
Goudar Chetan
Lin Henry
LULL Jonathan
Sabo Nicole
Cole Sean
Tharmalingam Tharmala
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53433304&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112016028285(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to BR122018011329A priority Critical patent/BR122018011329A2/pt
Publication of BR112016028285A2 publication Critical patent/BR112016028285A2/pt
Publication of BR112016028285B1 publication Critical patent/BR112016028285B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/16—Hollow fibers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48—Automatic or computerized control
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature
BR112016028285-0A 2014-06-04 2015-06-04 Método para uma colheita periódica prolongada, sistema de filtro de unidade única e método para cultivo de células que expressam proteína recombinante BR112016028285B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122018011329A BR122018011329A2 (pt) 2014-06-04 2015-06-04 método para colheita de uma proteína recombinante

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462007588P 2014-06-04 2014-06-04
US62/007,588 2014-06-04
PCT/US2015/034297 WO2015188009A1 (en) 2014-06-04 2015-06-04 Methods for harvesting mammalian cell cultures

Publications (2)

Publication Number Publication Date
BR112016028285A2 true BR112016028285A2 (pt) 2018-06-26
BR112016028285B1 BR112016028285B1 (pt) 2023-02-23

Family

ID=53433304

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112016028285-0A BR112016028285B1 (pt) 2014-06-04 2015-06-04 Método para uma colheita periódica prolongada, sistema de filtro de unidade única e método para cultivo de células que expressam proteína recombinante
BR122018011329A BR122018011329A2 (pt) 2014-06-04 2015-06-04 método para colheita de uma proteína recombinante

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122018011329A BR122018011329A2 (pt) 2014-06-04 2015-06-04 método para colheita de uma proteína recombinante

Country Status (24)

Country Link
US (3) US11384378B2 (pt)
EP (3) EP3521440B1 (pt)
JP (3) JP6695814B2 (pt)
KR (2) KR102598799B1 (pt)
CN (1) CN106687575B (pt)
AU (4) AU2015269365A1 (pt)
BR (2) BR112016028285B1 (pt)
CA (2) CA3195249A1 (pt)
CL (2) CL2016003096A1 (pt)
CY (1) CY1121217T1 (pt)
DK (1) DK3152317T3 (pt)
EA (2) EA039148B1 (pt)
ES (2) ES2709994T3 (pt)
HU (1) HUE042277T2 (pt)
IL (2) IL249150B (pt)
LT (1) LT3152317T (pt)
MX (3) MX2016015944A (pt)
PL (1) PL3152317T3 (pt)
PT (1) PT3152317T (pt)
SG (2) SG11201610143VA (pt)
SI (1) SI3152317T1 (pt)
TR (1) TR201900776T4 (pt)
WO (1) WO2015188009A1 (pt)
ZA (1) ZA201608303B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201506343QA (en) 2013-02-22 2015-09-29 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof
ES2717927T3 (es) 2013-02-22 2019-06-26 Genzyme Corp Procedimientos de cultivo por perfusión de microportadores y usos de los mismos
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
BR112017013423B1 (pt) * 2014-12-22 2023-04-11 Genzyme Corporation Métodos para cultivo de célula de mamífero
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JP7102391B2 (ja) * 2016-07-25 2022-07-19 レプリゲン・コーポレイション 交互タンジェンシャルフローによる高速収穫
JP7043125B2 (ja) * 2016-10-28 2022-03-29 旭化成メディカル株式会社 連続培養における有用物質の回収方法
CN107964037A (zh) * 2017-05-16 2018-04-27 浙江海隆生物科技有限公司 基于cho细胞表达***的重组猪瘟e2蛋白的纯化方法及应用
CA3073738A1 (en) 2017-08-31 2019-08-01 Massachusetts Institute Of Technology Hollow fiber membrane filtration systems and methods for manufacturing biologically-produced products
CN111344558A (zh) * 2017-10-06 2020-06-26 龙沙有限公司 使用拉曼光谱法自动控制细胞培养
CN111263631A (zh) 2017-10-26 2020-06-09 瑞普利金公司 微型交替切向流灌注过滤器、处理容器及其使用方法
EP3714036A1 (en) * 2017-11-20 2020-09-30 Lonza Ltd Process and system for propagating cell cultures while preventing lactate accumulation
GB201810772D0 (en) * 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
EP3874023A4 (en) * 2018-11-02 2022-08-17 Wuxi Biologics Ireland Limited ENHANCED PERFUSION CELL CULTURE PROCEDURE WITH CONTINUOUS HARVESTING AND WITHOUT CELL BLEEDING
US11680239B2 (en) 2018-12-31 2023-06-20 Repligen Corporation Filter for mammalian cell culture perfusion and clarification with hydrophobic hollow fiber
WO2021030573A1 (en) * 2019-08-13 2021-02-18 Repligen Corporation Control systems and methods for automated clarification of cell culture with high solids content
KR20220123463A (ko) * 2020-01-10 2022-09-06 론자 워커스빌 아이엔씨. 생물학적 공정 및 세포 집단을 정제하기 위한 필터 장치 및 방법
JP2023511291A (ja) * 2020-01-15 2023-03-17 ウーシー バイオロジクス アイルランド リミテッド 培養細胞から生産された生体物質を連続的に収穫するための装置及び方法
CN111808797A (zh) * 2020-07-28 2020-10-23 湖南赛诺生物科技股份有限公司 Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂
JP2023546736A (ja) * 2020-10-15 2023-11-07 エージーシー バイオロジクス，インコーポレーテッド 二重容器接線流濾過による連続的高細胞密度培養
US20220119759A1 (en) * 2020-10-19 2022-04-21 Emd Millipore Corporation Cascade Tangential Flow Filtration Systems for Perfusion of Cell Culture
JP2024507578A (ja) * 2021-02-25 2024-02-20 セキュアセル アクチェンゲゼルシャフト バイオテクノロジー用途のための流体サンプリングシステム、その操作方法および使用
FR3126713A1 (fr) * 2021-09-08 2023-03-10 Erypharm Procédé de production de cellules de culture à haute densité
CN114317392A (zh) * 2021-12-27 2022-04-12 无锡药明生物技术股份有限公司 优化细胞培养的方法
WO2023167584A1 (en) * 2022-03-01 2023-09-07 Biosanapharma B.V. Continuous manufacturing of a biological substance with process traceability
WO2023200918A1 (en) * 2022-04-14 2023-10-19 Terasaki Institute For Biomedical Innovation Systems and methods for recycling growth factors and other components
WO2023205075A1 (en) * 2022-04-22 2023-10-26 Coopersurgical, Inc. Methods of culturing umbilical cord mesenchymal stem cells
WO2024059235A2 (en) 2022-09-16 2024-03-21 Amgen Inc. A method for harvesting products from perfusion cultures

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5223428A (en) 1982-12-14 1993-06-29 Baxter International Inc. Method for in vitro culture of mammalian cells
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
JP2507552B2 (ja) * 1988-08-29 1996-06-12 株式会社ニッショー 細胞培養産生物の取出しおよび培地の交換方法
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US4937196A (en) 1989-08-18 1990-06-26 Brunswick Corporation Membrane bioreactor system
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DK0939121T4 (da) 1989-09-12 2008-02-04 Ahp Mfg B V TNF-bindende proteiner
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5378612A (en) 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DE69332981T2 (de) 1992-10-23 2004-05-19 Immunex Corp., Seattle Methoden zur herstellung löslicher, oligomerer proteine
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
US5721121A (en) 1995-06-06 1998-02-24 Genentech, Inc. Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
ES2253753T3 (es) 1995-06-29 2006-06-01 Immunex Corporation Citocina que induce apoptosis.
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6068775A (en) * 1998-04-13 2000-05-30 Circe Biomedical, Inc. Removal of agent from cell suspension
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
UY26723A1 (es) 2000-05-26 2001-12-28 Bristol Myers Squibb Co Moléculas mutantes de ctla4 solubles y usos de las mismas
US20040185535A1 (en) 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
US6903069B2 (en) 2000-10-02 2005-06-07 Novo Nordisk Health Care A/S Factor VII glycoforms
CA2451955C (en) * 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
DK2287288T3 (da) 2002-07-09 2013-01-07 Baxter Int Medium frit for animalsk protein til dyrkning af celler
DK2213685T3 (en) * 2002-09-06 2014-03-03 Medarex Llc Therapeutic anti-IL-1R1 monoclonal antibody
WO2004058800A2 (en) * 2002-12-23 2004-07-15 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
DE10312765A1 (de) 2003-03-21 2004-09-30 Bayer Technology Services Gmbh Vorrichtung und Verfahren zur Sterilisation flüssiger Medien mittels UV-Bestrahlung und Kurzzeiterhitzung
US20050100965A1 (en) * 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7795010B2 (en) * 2004-01-21 2010-09-14 Toray Industries, Inc. Fractionator and method of fractionation
EP2540815A1 (en) * 2004-03-05 2013-01-02 DSM IP Assets B.V. Perfusion cell culture
US7422875B2 (en) 2004-07-20 2008-09-09 Board Of Regents Of The University Of Nebraska Compositions and methods for increasing protein production
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
PL2343362T3 (pl) * 2006-07-14 2016-11-30 Udoskonalony sposób hodowania komórek
WO2008024769A2 (en) * 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
WO2008154014A2 (en) 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
EP2014760A1 (en) * 2007-06-13 2009-01-14 CMC Biopharmaceuticals A/S A method for producing a biopolymer (e.g. polypeptide) in a continuous fermentation process
MX2009013762A (es) 2007-06-15 2010-03-01 Amgen Inc Metodos para tratar medios de cultivo de celulas para uso en biorreactor.
EP3327132A3 (en) * 2007-08-09 2018-07-18 Wyeth LLC Use of perfusion to enhance production of fed-batch cell culture in bioreactors
PT2235197T (pt) 2007-12-27 2017-10-11 Baxalta Inc Processos para cultura de células
DE102008051574A1 (de) 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten
EP2356247B2 (en) 2008-11-12 2019-05-15 Baxalta Incorporated Method of producing serum-free insulin-free factor vii
KR101573972B1 (ko) 2009-07-31 2015-12-02 백스터 인터내셔널 인코포레이티드 Ａｄａｍｔｓ 단백질 발현을 위한 세포 배양 배지
BR112012009828B8 (pt) * 2009-10-26 2022-10-25 Hoffmann La Roche Método para a produção de uma imunoglobulina glicosilada e seu uso
CA2784741A1 (fr) * 2009-12-23 2011-06-30 Sanofi Pasteur Procede de culture de cellules adherentes
WO2012026978A2 (en) * 2010-08-25 2012-03-01 Jerry Shevitz Fluid filtration systems
JP5893051B2 (ja) * 2011-02-10 2016-03-23 クルセル ホランド ベー ヴェー 交互空気圧膜式細胞分離システム
SG192905A1 (en) 2011-02-23 2013-09-30 Amgen Inc Cell culture media for uvc exposure and methods related thereto
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
CN103517919B (zh) 2011-05-13 2016-11-16 欧克塔医药公司 在重组fviii的生产中提高真核细胞生产率的方法
CN107988166B (zh) 2011-07-01 2022-03-15 美国安进公司 哺乳动物细胞培养
WO2013040444A1 (en) 2011-09-16 2013-03-21 Amgen Inc. Pre-programmed non-feedback controlled continuous feeding of cell cultures
KR102091294B1 (ko) 2011-10-26 2020-04-16 암젠 인크 Uv 광으로의 노출로 인한 단백질 변형 및 분해의 감소 또는 제거 방법
US10955291B2 (en) 2012-03-15 2021-03-23 Amgen Inc. Methods of determining exposure to UV light
US10481164B2 (en) 2012-03-26 2019-11-19 Amgen Inc. Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
WO2014022102A1 (en) 2012-08-01 2014-02-06 Amgen Inc. Methods of using anti-apoptotic compounds to modulate one or more properties of a cell culture
TWI637057B (zh) 2012-11-09 2018-10-01 拜爾沙納有限公司 具交替生物反應器用途之不連續進料批次製程
ES2625510T3 (es) 2012-11-26 2017-07-19 Gambro Lundia Ab Sistema de soporte hepático
US10316282B2 (en) * 2013-03-19 2019-06-11 Cmc Biologics A/S Method for producing a product (e.g. polypeptide) in a continuous cell culture fermentation process

Also Published As

Publication number Publication date
AU2020294155A1 (en) 2021-01-28
EP3926051A1 (en) 2021-12-22
IL249150B (en) 2022-09-01
CA3195249A1 (en) 2015-12-10
EA201692498A1 (ru) 2017-05-31
US20170114381A1 (en) 2017-04-27
EP3521440A1 (en) 2019-08-07
ES2909630T3 (es) 2022-05-09
BR112016028285B1 (pt) 2023-02-23
EP3521440B1 (en) 2022-02-09
JP7377316B2 (ja) 2023-11-09
EP3152317B1 (en) 2019-01-02
CL2016003096A1 (es) 2017-11-03
HUE042277T2 (hu) 2019-06-28
SI3152317T1 (sl) 2019-03-29
ZA201608303B (en) 2023-06-28
EA202192126A3 (ru) 2022-03-31
DK3152317T3 (en) 2019-04-08
EP3926051B1 (en) 2024-05-08
EA202192126A2 (ru) 2021-11-30
PL3152317T3 (pl) 2019-08-30
JP7097404B2 (ja) 2022-07-07
CA2951046C (en) 2023-06-13
JP6695814B2 (ja) 2020-05-20
US20220136025A1 (en) 2022-05-05
CN106687575B (zh) 2021-04-30
CY1121217T1 (el) 2020-05-29
EA039148B1 (ru) 2021-12-10
MX2016015944A (es) 2017-08-15
IL294430A (en) 2022-09-01
SG11201610143VA (en) 2017-01-27
JP2017519497A (ja) 2017-07-20
KR20170015464A (ko) 2017-02-08
AU2019203538A1 (en) 2019-06-06
SG10202113019XA (en) 2021-12-30
BR122018011329A2 (pt) 2019-09-10
JP2020124207A (ja) 2020-08-20
MX2021008143A (es) 2021-08-11
MX2021008142A (es) 2021-08-11
AU2022224699A1 (en) 2022-09-22
JP2022126811A (ja) 2022-08-30
AU2020294155B2 (en) 2022-07-28
US11384378B2 (en) 2022-07-12
ES2709994T3 (es) 2019-04-22
WO2015188009A1 (en) 2015-12-10
PT3152317T (pt) 2019-04-18
WO2015188009A9 (en) 2017-01-26
KR20220054903A (ko) 2022-05-03
AU2015269365A1 (en) 2016-12-15
US20220356502A1 (en) 2022-11-10
LT3152317T (lt) 2019-03-12
KR102598799B1 (ko) 2023-11-07
AU2019203538B2 (en) 2020-10-08
KR102391259B1 (ko) 2022-04-26
CL2019001641A1 (es) 2019-10-25
CN106687575A (zh) 2017-05-17
EP3152317A1 (en) 2017-04-12
US11427848B2 (en) 2022-08-30
IL249150A0 (en) 2017-01-31
TR201900776T4 (tr) 2019-02-21
CA2951046A1 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
BR112016028285A2 (pt) métodos para colheita de culturas de células de mamíferos
SG11201703493SA (en) Cell culture insert
BR112017009540A2 (pt) biorreator usando macroalgas
GB201611982D0 (en) Cell culture
DK3253863T3 (da) Bioreaktorsystem til celledyrkning
DK3365107T3 (da) Cellekultur
EP3199614A4 (en) Cell culture system
EP3168291A4 (en) Cell culture system
IL250275A0 (en) Semi-continuous culture methods
ITUB20151992A1 (it) Piastra multi-pozzetto per colture cellulari
ES1113930Y (es) Unidad biologica para caracoles
PL3287521T3 (pl) Hodowla komórkowa
JP2016096066A5 (ja) 燃料電池システム
GB201608764D0 (en) Novel cell culture
DK3194574T3 (da) Fremgangsmåde til dyrkning af stamceller in vitro
SG11201609269TA (en) Method of culturing cells
ES1126855Y (es) Dispositivo para cultivo celular
TWI563082B (en) Cell culture device
SG10202010002RA (en) Cell culture
GB201421342D0 (en) Cell culture
ES1145560Y (es) Soporte para cultivo semihidroponico
TH1601003875A (th) วิธีสำหรับผลิตเซลล์แสงอาทิตย์
TH1501006905A (th) วิธีสำหรับการผลิตส่วนเพาะเลี้ยงเซลล์รูปแผ่น
FR3016372B1 (fr) Procede de preparation de cellules pluripotentes induites
ES1111081Y (es) Soporte de bateria de esparcido para maquina agricola

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/06/2015, OBSERVADAS AS CONDICOES LEGAIS